Study of the capillary electrophoresis profile of intact α-1-acid glycoprotein isoforms as a biomarker of atherothrombosis

• Published in: Analyst (London) Vol. 136; no. 4; pp. 816 - 822
• Main Authors: Puerta, Angel, Díez-Masa, José Carlos, Martín-Álvarez, Pedro Jesús, Martín-Ventura, José Luis, Barbas, Coral, Tuñón, José, Egido, Jesús, de Frutos, Mercedes
• Format: Journal Article
• Language: English
• Published: Cambridge Royal Society of Chemistry 21.02.2011
• Subjects: Analytical chemistry; Aortic Aneurysm, Abdominal - metabolism; Biomarkers - metabolism; Carotid Artery Diseases - metabolism; Case-Control Studies; Chemistry; Chromatographic methods and physical methods associated with chromatography; Chromatography, Affinity; Discriminant Analysis; Electrophoresis, Capillary - methods; Exact sciences and technology; Humans; Orosomucoid - isolation & purification; Orosomucoid - metabolism; Other chromatographic methods; Pilot Projects; Plaque, Atherosclerotic - metabolism; Protein Isoforms - isolation & purification; Protein Isoforms - metabolism; Thrombosis - metabolism; Human; Plasma; Discriminant analysis; Zone electrophoresis; Purification; Immunoaffinity chromatography; Capillary electrophoresis; Sample; Glycoprotein; Biological marker; Time; Method; Biological compound; Classification; Aorta; Serum; Peak
• ISSN: 0003-2654; 1364-5528
• DOI: 10.1039/c0an00320d

α-1-Acid glycoprotein (AGP) is a serum glycoprotein that presents several isoforms. Changes in the isoforms of AGP have been related to different pathological states including cardiovascular diseases (CVDs) such as acute myocardial infarction. However, to our knowledge, the role of variations of AGP isoforms as a potential biomarker of atherothrombosis has not been addressed. In this work, a preliminary study about differences in the capillary zone electrophoresis (CZE) profile of intact (non-hydrolyzed) AGP isoforms between healthy individuals and patients with atherothrombosis, specifically abdominal aortic aneurysm (AAA) and carotid atherosclerosis (CTA), has been performed. Biological samples (plasmas and sera) were analyzed by CZE after immunoaffinity chromatography purification. Up to 13 peaks corresponding to groups of isoforms of intact AGP from plasma samples were detected by CZE-UV. Electrophoretic profiles were aligned, peaks assigned, and linear discriminant analysis (LDA) of percentage of the corrected areas of AGP peaks was employed to discriminate and classify the CZE profiles of AGP samples. LDA enabled to accomplish 92.9% of correct classification of the AGP samples when the three groups of samples were considered. Besides, the LDA model showed high predictive power in the groups healthy vs. sick, healthy vs. AAA, and healthy vs. CTA. The described method was a successful approach to study the potential of AGP isoforms profile as a biomarker of atherothrombosis. To the best of our knowledge this has been the first time that a possible role of the CZE profile of intact AGP isoforms as a biomarker of vascular diseases has been demonstrated. Statistical analysis shows that the CE profile of intact AGP purified by immunoaffinity chromatography from plasma is a potential biomarker of atherothrombosis.